Update on COVID-19 therapeutics for solid organ transplant recipients, including the omicron surge
RK Avery - Transplantation, 2022 - journals.lww.com
Major changes have occurred in therapeutics for coronavirus-19 (COVID-19) infection over
the past 12–18 mo, most notably in early outpatient therapy. In most cases, solid organ …
the past 12–18 mo, most notably in early outpatient therapy. In most cases, solid organ …
[HTML][HTML] A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.
Y Mohamed, YA El-Maradny, AK Saleh… - Biomedicine & …, 2022 - Elsevier
The healthy immune system eliminates pathogens and maintains tissue homeostasis
through extraordinarily complex networks with feedback systems while avoiding potentially …
through extraordinarily complex networks with feedback systems while avoiding potentially …
Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID‐19: a self‐controlled case series study
Summary Background and Aim To investigate and quantify the risks of AKI and ALI
associated with remdesivir use, given the underlying diseases of SARS‐CoV‐2 infection …
associated with remdesivir use, given the underlying diseases of SARS‐CoV‐2 infection …
Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the …
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) arose in December 2019
in China rapidly evolving to the Coronavirus Disease 2019 (COVID-19) pandemic. Since …
in China rapidly evolving to the Coronavirus Disease 2019 (COVID-19) pandemic. Since …
Bacterial and fungal co-infections with SARS-CoV-2 in solid organ recipients: a retrospective study
M Shafiekhani, Z Shekari, A Boorboor, Z Zare… - Virology Journal, 2022 - Springer
Abstract Background SARS-CoV-2, a novel corona virus, has caused clusters of fatal
pneumonia worldwide. Immune compromised patients are among the high risk groups with …
pneumonia worldwide. Immune compromised patients are among the high risk groups with …
[HTML][HTML] COVID-19 infection rate after urgent versus elective total hip replacement among unvaccinated individuals: a multicenter prospective cohort amid the COVID …
SP Mirghaderi, E Sheikhbahaei, M Salimi… - Annals of Medicine and …, 2022 - Elsevier
Background Due to the COVID-19 pandemic, hospitals have become unsafe for patients as
potential sources of virus transmission. This study aims to determine the COVID-19 infection …
potential sources of virus transmission. This study aims to determine the COVID-19 infection …
COVID-19 versus applied infection control policies in a Major Transplant Center in Iran
Abstract Background Since Shiraz Transplant Center is one of the major transplant centers
in Iran and the Middle East, this study was conducted to evaluate outcomes of the applied …
in Iran and the Middle East, this study was conducted to evaluate outcomes of the applied …
Evaluation and Comparison of Mucormycosis Patients' Features Undergoing Functional Endoscopic Sinus Surgery Prior to and during the COVID‐19 Pandemic: A …
Background. Rhinocerebral mucormycosis is a serious invasive fungal infection that is one
of the most aggressive and lethal of invasive mycoses. The coronavirus disease (COVID‐19) …
of the most aggressive and lethal of invasive mycoses. The coronavirus disease (COVID‐19) …
[HTML][HTML] Incidence, Clinicomicrobiological Characteristics, Risk Factors, and Treatment Outcomes of Bacterial Infections Following Liver Transplantation in Pediatrics …
Background: Liver transplantation (LT) is the definitive treatment for patients with advanced
liver failure. Bacterial infections are common consequences of organ transplantation …
liver failure. Bacterial infections are common consequences of organ transplantation …